- Home
- SBGI vs MDXG Comparison
SBGI vs MDXG Comparison
Compare SBGI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBGI | MDXG |
|---|---|---|
| Founded | 1986 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 530.2M |
| IPO Year | 2023 | 2007 |
Fundamental Metrics
Financial Performance| Metric | SBGI | MDXG |
|---|---|---|
| Price | $13.96 | $3.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $22.00 | $9.00 |
| AVG Volume (30 Days) | 397.8K | ★ 1.5M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 6.56% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $3,169,000,000.00 | $418,630,000.00 |
| Revenue This Year | $12.37 | N/A |
| Revenue Next Year | N/A | $13.02 |
| P/E Ratio | $51.04 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $11.89 | $3.03 |
| 52 Week High | $17.88 | $7.99 |
Technical Indicators
Market Signals| Indicator | SBGI | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 42.52 | 51.81 |
| Support Level | $13.02 | $3.45 |
| Resistance Level | $15.49 | $3.80 |
| Average True Range (ATR) | 0.49 | 0.12 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 31.14 | 65.71 |
Price Performance
Historical ComparisonAbout SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.